These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 33429003)
1. LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3. Sharma U; Barwal TS; Khandelwal A; Malhotra A; Rana MK; Singh Rana AP; Imyanitov EN; Vasquez KM; Jain A Biochimie; 2021 Mar; 182():99-107. PubMed ID: 33429003 [TBL] [Abstract][Full Text] [Related]
2. Relevance and mechanism of STAT3/miR-221-3p/Fascin-1 axis in EGFR TKI resistance of triple-negative breast cancer. Jin LL; Lu HJ; Shao JK; Wang Y; Lu SP; Huang BF; Hu GN; Jin HC; Wang CQ Mol Cell Biochem; 2024 Nov; 479(11):3037-3047. PubMed ID: 38145448 [TBL] [Abstract][Full Text] [Related]
3. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development. Jin C; Yan B; Lu Q; Lin Y; Ma L Tumour Biol; 2016 Jun; 37(6):7383-94. PubMed ID: 26676637 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer. Hua K; Deng X; Hu J; Ji C; Yu Y; Li J; Wang X; Fang L J Exp Clin Cancer Res; 2020 Apr; 39(1):58. PubMed ID: 32248842 [TBL] [Abstract][Full Text] [Related]
5. Genomic regulation of invasion by STAT3 in triple negative breast cancer. McDaniel JM; Varley KE; Gertz J; Savic DS; Roberts BS; Bailey SK; Shevde LA; Ramaker RC; Lasseigne BN; Kirby MK; Newberry KM; Partridge EC; Jones AL; Boone B; Levy SE; Oliver PG; Sexton KC; Grizzle WE; Forero A; Buchsbaum DJ; Cooper SJ; Myers RM Oncotarget; 2017 Jan; 8(5):8226-8238. PubMed ID: 28030809 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of the long non-coding RNA ZFAS1 is associated with cell proliferation, migration and invasion in breast cancer. Fan S; Fan C; Liu N; Huang K; Fang X; Wang K Mol Med Rep; 2018 May; 17(5):6405-6412. PubMed ID: 29532866 [TBL] [Abstract][Full Text] [Related]
7. STAT3 Targets Ma JH; Qi J; Lin SQ; Zhang CY; Liu FY; Xie WD; Li X Mol Cancer Res; 2019 Nov; 17(11):2184-2195. PubMed ID: 31427441 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer. Dees S; Pontiggia L; Jasmin JF; Mercier I Cancer Biol Ther; 2020 Jun; 21(6):506-521. PubMed ID: 32164483 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA LINC-PINT attenuates paclitaxel resistance in triple-negative breast cancer cells via targeting the RNA-binding protein NONO. Chen J; Zhu M; Zou L; Xia J; Huang J; Deng Q; Xu R Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):801-809. PubMed ID: 32632453 [TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth. Zhang DD; Li Y; Xu Y; Kim J; Huang S Oncogene; 2019 Feb; 38(7):1106-1120. PubMed ID: 30209363 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling. Vishnubalaji R; Alajez NM Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372 [TBL] [Abstract][Full Text] [Related]
12. STAT3-induced NCK1 elevation promotes migration of triple-negative breast cancer cells via regulating ERK1/2 signaling. He P; Sheng J; Qi J; Bai X; Li J; Wang F; Yuan Y; Zheng X Mol Biol Rep; 2022 Jan; 49(1):267-278. PubMed ID: 34846647 [TBL] [Abstract][Full Text] [Related]
13. LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer. Yan J; Wang R; Wu Z J BUON; 2019; 24(2):535-542. PubMed ID: 31128002 [TBL] [Abstract][Full Text] [Related]
14. LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19. Wang N; Hou M; Zhan Y; Sheng X J Cell Biochem; 2019 Sep; 120(9):15083-15088. PubMed ID: 31026090 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer. Fan CN; Ma L; Liu N J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490 [TBL] [Abstract][Full Text] [Related]
16. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers. Liu D Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968 [TBL] [Abstract][Full Text] [Related]
17. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression. Fan H; Yuan J; Li X; Ma Y; Wang X; Xu B; Li X Biomed Pharmacother; 2020 May; 125():109987. PubMed ID: 32058222 [TBL] [Abstract][Full Text] [Related]
18. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling. Zheng S; Li M; Miao K; Xu H J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053 [TBL] [Abstract][Full Text] [Related]
19. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448. Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of long non-coding RNA HOST2 inhibits the proliferation of triple negative breast cancer via regulation of the let-7b/CDK6 axis. Zhang Y; Zhang H; Kang H; Huo W; Zhou Y; Zhang Y Int J Mol Med; 2019 Feb; 43(2):1049-1057. PubMed ID: 30483747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]